Gland Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA1,4371,7340
EBIT1,3381,6240
Earning Per Share627347
Expenses2,1612,8912,600
Net Profit9971,212781
Net Profit Margin292822
Operating Profit Margin413935
Profit Before Tax1,3351,6191,055
Dividends Per Share000
Operation Revenue3,5984,6253,865

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Gland Pharma is 0 as of 3/5/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202020212023
Operating Activities701605364
Investing Activities-766-1,5241,208
Financing Activities-71,23815
Others000
Net Cash Flow-723191,587

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Gland Pharma is 364 as of 3/5/2024